Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura.

@article{Buchanan2001OutcomeMA,
  title={Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura.},
  author={George R. Buchanan and Leah M Adix},
  journal={Seminars in thrombosis and hemostasis},
  year={2001},
  volume={27 3},
  pages={277-85}
}
Therapy for children with acute idiopathic thrombocytopenic purpura (ITP) has been controversial, in great part because it is not evidence based. Some physicians are activists, treaters, or interventionists with regard to therapy of ITP whereas others have been described as nontreaters or noninterventionists. Platelet count (which is often extremely low in ITP) has generally been employed as a surrogate measure of hemorrhagic risk even though life-threatening or fatal bleeding is rare… CONTINUE READING